These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4114280)

  • 1. Inhibition of microsomal drug-metabolizing enzymes from rat liver by various 4-hydroxycoumarin derivatives.
    Christensen F; Wissing F
    Biochem Pharmacol; 1972 Apr; 21(7):975-84. PubMed ID: 4114280
    [No Abstract]   [Full Text] [Related]  

  • 2. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro inhibition of rat and human liver microsomal enzymes by 4-hydroxycoumarin anticoagulants and related compounds.
    Deckert FW; Remmer HK
    Chem Biol Interact; 1972 Sep; 5(4):255-63. PubMed ID: 5075757
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of some effects of dimethyl sulphoxide and dimethyl sulphone on rat liver microsomal enzymes.
    Stock BH; Fouts JR
    Biochem Pharmacol; 1971 Jul; 20(7):1525-36. PubMed ID: 4399524
    [No Abstract]   [Full Text] [Related]  

  • 5. The complexity of the inhibitory action of dicoumarol on the mixed function oxidase system of rat liver microsomes.
    Wissing F; Christensen F
    Biochem Pharmacol; 1973 Mar; 22(5):581-9. PubMed ID: 4120818
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethanol and induction of microsomal drug-metabolizing enzymes in the rat.
    Singlevich TE; Barboriak JJ
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):284-90. PubMed ID: 4399885
    [No Abstract]   [Full Text] [Related]  

  • 9. Additive and synergistic inhibition of mammalian microsomal enzyme functions by piperonyl butoxide, safrole and other methylenedioxyphenyl derivatives.
    Friedman MA; Arnold E; Bishop Y; Epstein SS
    Experientia; 1971 Sep; 27(9):1052-4. PubMed ID: 5116130
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 11. On the inhibition of microsomal drug metabolism by SKF 525-A.
    Jenner S; Netter KJ
    Biochem Pharmacol; 1972 Jul; 21(14):1921-7. PubMed ID: 4649342
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hexachlorobenzene on microsomal enzyme systems.
    Turner JC; Green RS
    Biochem Pharmacol; 1974 Sep; 23(17):2387-90. PubMed ID: 4429573
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic microsomal ethanol oxidizing system (MEOS): differentiation from alcohol dehydrogenase and NADPH oxidase.
    Lieber CS; Rubin E; DeCarli LM
    Biochem Biophys Res Commun; 1970 Aug; 40(4):858-65. PubMed ID: 4395603
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 1,10-phenanthroline on drug oxidizing enzymes of rat liver microsomes.
    Chyapil M; Ryan JN
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1292-9. PubMed ID: 5160695
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of microsomal drug hydroxylation in lung and liver of various species.
    Oppelt WW; Zange M; Ross WE; Remmer H
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):43-56. PubMed ID: 5524315
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of spironolactone and ethylestrenol on benzo(a)pyrene hydroxylase (EC 1.14.1.1) and other chemical constituents of hepatic microsomes.
    Solymoss B; Toth S; Varga S; Werringloer J; Zsigmond G
    Can J Physiol Pharmacol; 1971 Sep; 49(9):841-6. PubMed ID: 4401249
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors involved in the inhibition of drug metabolism by (-)-emetine.
    Johnson RK; Mazel P; Donahue JD; Jondorf WR
    Biochem Pharmacol; 1971 May; 20(5):955-66. PubMed ID: 4400643
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of microsomal biotransformation in the liver in cholestasis.
    Hutterer F; Bacchin PG; Raisfeld IH; Schenkman JB; Schaffner F; Popper H
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):702-6. PubMed ID: 4391840
    [No Abstract]   [Full Text] [Related]  

  • 19. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monooxygenase drug metabolizing activity in CaCl 2 -aggregated hepatic microsomes from rat liver.
    Kupfer D; Levin E
    Biochem Biophys Res Commun; 1972 May; 47(3):611-8. PubMed ID: 4402636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.